Zack Lynch, whose Neurotechnology Industry Organization represents 50 smaller companies pursuing treatments for brain disorders, worries that if the downturn continues, "we may lose an entire generation of potential brain drugs" as companies vanish.
So for his Ignite NYC talk, he performed a series of experiments to find just what sorts of obscuring techniques can defeat a common facial recognition algorithm known as Eigenfaces, testing an off-the-shelf implementation of that algorithm in a program called Neurotechnology.